These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cefepime: a rare cause of encephalopathy. McNally A; Pithie A; Jardine D Intern Med J; 2012 Jun; 42(6):732-3. PubMed ID: 22697161 [No Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa bacteraemia in cancer patients. Krcmery V; Koprnova J; Gogova M; Grey E; Korcova J J Infect; 2006 Jun; 52(6):461-3. PubMed ID: 16621000 [No Abstract] [Full Text] [Related]
7. [New cephalosporin with favorable pharmacokinetic properties]. Gabler-Sandberger E MMW Munch Med Wochenschr; 1983 Sep; 125(35):75-6. PubMed ID: 6415426 [No Abstract] [Full Text] [Related]
8. Cefepime: an underrecognized cause of nonconvulsive status epilepticus. Lichaa H; Rachoin JS; Cerceo E; Rajput V; Surkis W J Hosp Med; 2010 Mar; 5(3):E18-9. PubMed ID: 20235298 [No Abstract] [Full Text] [Related]
9. Tissue penetration and exposure of cefepime in patients with diabetic foot infections. So W; Kuti JL; Shepard A; Nugent J; Nicolau DP Int J Antimicrob Agents; 2016 Mar; 47(3):247-8. PubMed ID: 26897754 [No Abstract] [Full Text] [Related]
10. The new cephalosporins. Villar LA; Donta ST J Iowa Med Soc; 1982 Jun; 72(6):246-8. PubMed ID: 7108289 [No Abstract] [Full Text] [Related]
11. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Leibovici L; Yahav D; Paul M Clin Infect Dis; 2010 Dec; 51(11):1350-1; author reply 1351-2. PubMed ID: 21050112 [No Abstract] [Full Text] [Related]
12. Prescribing guidelines for severe Pseudomonas infections. Giamarellou H J Antimicrob Chemother; 2002 Feb; 49(2):229-33. PubMed ID: 11815561 [No Abstract] [Full Text] [Related]